a) Covaxin
b) Covishield
c) Sinopharm
d) Johnson & Johnson
Bharat Biotech is confident about obtaining the World Health Organization’s (WHO) Emergency Use Listing for its COVID-19 vaccine, Covaxin. The drug manufacturer has submitted 90 percent of the documentation required for emergency use listing by the global health body.